As a SARM, YK-11 is designed to selectively stimulate muscle and bone tissue growth while limiting effects on other organs. This compound stands out from other SARMs due to its steroidal structure, allowing it to partially mimic anabolic steroids’ muscle-enhancing effects but with selective androgen receptor targeting that limits unwanted androgenic effects in the body. Studies have shown YK-11’s capability to increase follistatin levels, which inhibits myostatin—a known muscle growth inhibitor—suggesting it could support lean muscle mass development. Typically used in 4 to 8-week cycles, users may take YK-11 at doses ranging from 5 to 10 mg per day, though reliable information on half-life and long-term safety is still unavailable due to the lack of clinical trials.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Myostane by Driada Medical, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.